Appropriate solution selection at the administering epirubicin hydrochloride to the breast cancer patients

被引：2
|
作者：
Masuda, N. [1 ]
Amani, S. [2 ]
Nishikata, M. [3 ]
Matsuyama, K. [3 ]
Tsujinaka, T. [1 ]
机构：
[1] Osaka Natl Hosp, Osaka, Japan
[2] Sakai Municipal Hosp, Sakai, Osaka, Japan
[3] Mukogawa Womens Univ, Sch Pharmaceut Sci, Ashiya, Japan
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90912-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [41] Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
    Mele, Teresa
    Generali, Daniele
    Fox, Stephen
    Brizzi, Maria Pia
    Bersiga, Alessandra
    Milani, Manuela
    Allevi, Giovanni
    Bonardi, Simone
    Aguggini, Sergio
    Volante, Marco
    Dogliotti, Luigi
    Bottini, Alberto
    Harris, Adrian
    Berruti, Alfredo
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 795 - 804
  • [42] Gemcitabine and epirubicin in patients with metastatic breast cancer:: A phase I/II study
    Campone, Mario
    Fumoleau, Pierre
    Viens, Patrice
    Dieras, Wronique
    Pujade-Lauraine, Eric
    Serin, Daniel
    Petit, Thierry
    Espie, Marc
    Kayitalire, Louis
    Bozec, Laurence
    Pouillart, Pierre
    BREAST, 2006, 15 (05): : 601 - 609
  • [43] COMPARATIVE PHARMACOKINETICS AND METABOLISM OF DOXORUBICIN AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    ROBERT, J
    VRIGNAUD, P
    NGUYENNGOC, T
    ILIADIS, A
    MAURIAC, L
    HURTELOUP, P
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 633 - 640
  • [44] A PROSPECTIVE RANDOMIZED COMPARISON OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER
    JAIN, KK
    CASPER, ES
    GELLER, NL
    HAKES, TB
    KAUFMAN, RJ
    CURRIE, V
    SCHWARTZ, W
    CASSIDY, C
    PETRONI, GR
    YOUNG, CW
    WITTES, RE
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 818 - 826
  • [45] Is adjuvant hypofractionated radiotherapy appropriate for elderly patients with breast cancer?
    Abram Recht
    Nature Clinical Practice Oncology, 2005, 2 : 244 - 245
  • [46] Is adjuvant hypofractionated radiotherapy appropriate for elderly patients with breast cancer?
    Recht, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (05): : 244 - 245
  • [47] Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic breast cancer: The French experience
    Catimel, G
    Spielmann, M
    Dieras, V
    TubianaHulin, M
    Bonneterre, J
    Pouillart, P
    Kayitalire, L
    Guastalla, JP
    Graffand, N
    Garet, F
    Dumortier, A
    PellaeCosset, B
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S8 - S12
  • [48] Paclitaxel plus epirubicin in advanced breast cancer
    Conte, PF
    Gennari, A
    Salvadori, B
    Pazzagli, I
    Bengala, C
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 40 - 44
  • [49] EPIRUBICIN CARDIOTOXICITY ON BREAST CANCER ADJUVANT SETTING
    Faustino, I.
    Sousa, S.
    Rego, S.
    Couto, R.
    Mauricio, M. J.
    Pereira, D.
    Afonso, N.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 94 - 94
  • [50] Paclitaxel: Epirubicin in metastatic breast cancer - a review
    Razis, ED
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 593 - 598
12345